Jeanne Wei
Concepts (338)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Serum Response Factor | 11 | 2024 | 42 | 4.440 |
Why?
| Transcription Factors | 9 | 2024 | 563 | 2.820 |
Why?
| Myocardium | 14 | 2024 | 429 | 2.040 |
Why?
| Delirium | 2 | 2023 | 47 | 1.680 |
Why?
| Lipopolysaccharides | 2 | 2024 | 191 | 1.650 |
Why?
| Aging | 10 | 2016 | 688 | 1.530 |
Why?
| Health Literacy | 2 | 2023 | 129 | 1.490 |
Why?
| Doxorubicin | 6 | 2024 | 230 | 1.450 |
Why?
| Actins | 3 | 2022 | 118 | 1.420 |
Why?
| Amino Acids, Essential | 4 | 2024 | 130 | 1.300 |
Why?
| Porphyromonas gingivalis | 2 | 2024 | 16 | 1.150 |
Why?
| MicroRNAs | 4 | 2016 | 354 | 1.090 |
Why?
| Gene Expression Regulation | 12 | 2016 | 979 | 1.070 |
Why?
| Heart | 6 | 2016 | 326 | 1.060 |
Why?
| Accidental Falls | 3 | 2022 | 98 | 1.060 |
Why?
| Mice | 17 | 2024 | 5720 | 1.000 |
Why?
| Mitochondria | 7 | 2024 | 397 | 0.960 |
Why?
| Transcriptome | 3 | 2024 | 313 | 0.950 |
Why?
| Paraffin Embedding | 1 | 2024 | 53 | 0.940 |
Why?
| Formaldehyde | 1 | 2024 | 52 | 0.940 |
Why?
| Dietary Supplements | 4 | 2024 | 441 | 0.910 |
Why?
| Valine | 1 | 2024 | 58 | 0.910 |
Why?
| Sequence Analysis, RNA | 1 | 2024 | 91 | 0.900 |
Why?
| Amino Acids, Branched-Chain | 1 | 2024 | 38 | 0.900 |
Why?
| Aged | 28 | 2024 | 9272 | 0.870 |
Why?
| Glucose | 2 | 2017 | 340 | 0.860 |
Why?
| Microglia | 1 | 2024 | 141 | 0.830 |
Why?
| Heart Failure | 5 | 2019 | 454 | 0.820 |
Why?
| Physical Therapists | 1 | 2021 | 9 | 0.760 |
Why?
| Proteomics | 1 | 2024 | 328 | 0.760 |
Why?
| Sirtuins | 1 | 2021 | 11 | 0.750 |
Why?
| Animals | 20 | 2024 | 13150 | 0.740 |
Why?
| Alzheimer Disease | 4 | 2024 | 317 | 0.720 |
Why?
| Oxidative Stress | 4 | 2024 | 768 | 0.720 |
Why?
| Humans | 49 | 2024 | 49827 | 0.710 |
Why?
| Geriatrics | 4 | 2019 | 46 | 0.700 |
Why?
| Genetic Variation | 1 | 2021 | 214 | 0.690 |
Why?
| Primary Health Care | 2 | 2014 | 353 | 0.670 |
Why?
| Histones | 2 | 2022 | 315 | 0.640 |
Why?
| RNA, Messenger | 7 | 2021 | 1105 | 0.620 |
Why?
| Sirtuin 2 | 1 | 2017 | 12 | 0.610 |
Why?
| Cytoskeletal Proteins | 1 | 2017 | 49 | 0.560 |
Why?
| Cell Line | 6 | 2024 | 1002 | 0.560 |
Why?
| Dementia | 2 | 2012 | 141 | 0.560 |
Why?
| Mitochondria, Heart | 1 | 2016 | 35 | 0.540 |
Why?
| Gene Expression Profiling | 3 | 2024 | 1031 | 0.530 |
Why?
| Gastrostomy | 2 | 2014 | 55 | 0.530 |
Why?
| Oxygen Consumption | 1 | 2015 | 180 | 0.480 |
Why?
| Metformin | 1 | 2015 | 64 | 0.480 |
Why?
| Alternative Splicing | 2 | 2021 | 57 | 0.470 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 166 | 0.460 |
Why?
| Physicians, Primary Care | 1 | 2014 | 43 | 0.450 |
Why?
| beta-Galactosidase | 1 | 2013 | 33 | 0.440 |
Why?
| Hospitalization | 3 | 2018 | 653 | 0.440 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2013 | 78 | 0.430 |
Why?
| Blood Glucose | 1 | 2015 | 432 | 0.430 |
Why?
| Eating | 2 | 2024 | 162 | 0.430 |
Why?
| Antibiotics, Antineoplastic | 3 | 2017 | 78 | 0.410 |
Why?
| Aged, 80 and over | 13 | 2021 | 3125 | 0.410 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2012 | 73 | 0.410 |
Why?
| Health Services for the Aged | 1 | 2012 | 30 | 0.400 |
Why?
| Malnutrition | 1 | 2012 | 87 | 0.390 |
Why?
| Nitric Oxide | 1 | 2013 | 253 | 0.380 |
Why?
| Cardiomegaly | 1 | 2011 | 34 | 0.380 |
Why?
| Quality Improvement | 2 | 2023 | 212 | 0.370 |
Why?
| Signal Transduction | 4 | 2024 | 1617 | 0.370 |
Why?
| Longevity | 2 | 2010 | 80 | 0.370 |
Why?
| Patient Discharge | 2 | 2013 | 322 | 0.370 |
Why?
| Caregivers | 2 | 2023 | 206 | 0.370 |
Why?
| Rats | 5 | 2024 | 3300 | 0.360 |
Why?
| Education, Medical, Graduate | 1 | 2012 | 208 | 0.350 |
Why?
| Amino Acid Sequence | 5 | 2011 | 587 | 0.340 |
Why?
| Chronic Disease | 1 | 2012 | 563 | 0.340 |
Why?
| Collagen | 1 | 2010 | 206 | 0.330 |
Why?
| Endocarditis, Bacterial | 1 | 2009 | 44 | 0.320 |
Why?
| Anabolic Agents | 2 | 2019 | 33 | 0.310 |
Why?
| NADH Dehydrogenase | 1 | 2008 | 9 | 0.310 |
Why?
| Electron Transport Complex I | 1 | 2008 | 23 | 0.310 |
Why?
| Mice, Transgenic | 4 | 2014 | 555 | 0.300 |
Why?
| Male | 18 | 2024 | 25093 | 0.300 |
Why?
| Promoter Regions, Genetic | 4 | 2017 | 477 | 0.300 |
Why?
| Protein Structure, Tertiary | 2 | 2021 | 253 | 0.300 |
Why?
| Female | 24 | 2021 | 26329 | 0.290 |
Why?
| Ventricular Pressure | 1 | 2006 | 15 | 0.290 |
Why?
| Insulin-Like Growth Factor I | 3 | 2016 | 137 | 0.280 |
Why?
| Isoproterenol | 1 | 2006 | 57 | 0.280 |
Why?
| Trans-Activators | 3 | 2016 | 134 | 0.270 |
Why?
| Drug Therapy | 1 | 2006 | 46 | 0.270 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 22 | 0.270 |
Why?
| Cachexia | 1 | 2006 | 25 | 0.260 |
Why?
| Nuclear Proteins | 3 | 2016 | 243 | 0.260 |
Why?
| Protein Isoforms | 2 | 2021 | 119 | 0.260 |
Why?
| Residence Characteristics | 1 | 2006 | 151 | 0.250 |
Why?
| Cells, Cultured | 4 | 2015 | 1571 | 0.250 |
Why?
| Molecular Sequence Data | 4 | 2008 | 797 | 0.250 |
Why?
| Self Care | 1 | 2006 | 135 | 0.250 |
Why?
| Breast Neoplasms | 4 | 2017 | 1169 | 0.250 |
Why?
| Cognition Disorders | 1 | 2006 | 218 | 0.240 |
Why?
| Independent Living | 2 | 2021 | 41 | 0.240 |
Why?
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 90 | 0.240 |
Why?
| Lysine | 2 | 2022 | 90 | 0.240 |
Why?
| Tissue Fixation | 1 | 2024 | 36 | 0.240 |
Why?
| Interleukin-18 | 1 | 2024 | 27 | 0.230 |
Why?
| Isoleucine | 1 | 2024 | 27 | 0.230 |
Why?
| RNA, Ribosomal, 16S | 1 | 2024 | 109 | 0.230 |
Why?
| Human Growth Hormone | 2 | 2017 | 50 | 0.230 |
Why?
| Leucine | 1 | 2024 | 116 | 0.220 |
Why?
| Lewy Body Disease | 1 | 2023 | 9 | 0.220 |
Why?
| Proteins | 1 | 2006 | 341 | 0.220 |
Why?
| Ternary Complex Factors | 1 | 2022 | 5 | 0.220 |
Why?
| Cell Size | 2 | 2014 | 45 | 0.210 |
Why?
| Anilides | 1 | 2022 | 19 | 0.210 |
Why?
| Estrogens, Conjugated (USP) | 1 | 2002 | 3 | 0.210 |
Why?
| Blood Proteins | 1 | 2023 | 82 | 0.210 |
Why?
| Mice, Inbred C57BL | 4 | 2016 | 1806 | 0.210 |
Why?
| Benzamides | 1 | 2022 | 51 | 0.210 |
Why?
| NIH 3T3 Cells | 3 | 2008 | 52 | 0.210 |
Why?
| Ambulatory Care Facilities | 1 | 2023 | 125 | 0.210 |
Why?
| Base Sequence | 2 | 2017 | 650 | 0.210 |
Why?
| Cues | 1 | 2021 | 49 | 0.200 |
Why?
| Genome | 2 | 2021 | 67 | 0.200 |
Why?
| Age Factors | 5 | 2010 | 1090 | 0.200 |
Why?
| Adenosine Triphosphate | 1 | 2022 | 234 | 0.190 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 440 | 0.190 |
Why?
| Up-Regulation | 2 | 2014 | 450 | 0.190 |
Why?
| Cytokines | 1 | 2024 | 612 | 0.190 |
Why?
| Genetic Loci | 1 | 2021 | 49 | 0.190 |
Why?
| Exons | 1 | 2021 | 95 | 0.180 |
Why?
| Zinc | 1 | 2021 | 53 | 0.180 |
Why?
| Animals, Newborn | 2 | 2014 | 366 | 0.180 |
Why?
| Rats, Sprague-Dawley | 1 | 2024 | 1595 | 0.180 |
Why?
| Focus Groups | 1 | 2021 | 188 | 0.180 |
Why?
| United States | 5 | 2019 | 4838 | 0.180 |
Why?
| Cell Line, Tumor | 1 | 2024 | 1402 | 0.170 |
Why?
| Ventricular Function, Left | 2 | 2017 | 154 | 0.170 |
Why?
| Adult | 7 | 2023 | 13160 | 0.170 |
Why?
| Food, Formulated | 1 | 2019 | 41 | 0.170 |
Why?
| Conserved Sequence | 2 | 2011 | 56 | 0.160 |
Why?
| Blood | 1 | 2017 | 28 | 0.150 |
Why?
| Culture Media | 1 | 2017 | 93 | 0.150 |
Why?
| Chemokines | 1 | 2017 | 77 | 0.150 |
Why?
| Tissue Distribution | 3 | 2008 | 164 | 0.150 |
Why?
| Stroke Volume | 1 | 2017 | 115 | 0.140 |
Why?
| Down Syndrome | 1 | 2018 | 91 | 0.140 |
Why?
| Cerebrovascular Disorders | 2 | 2018 | 54 | 0.140 |
Why?
| Neocortex | 1 | 2016 | 8 | 0.140 |
Why?
| Homeostasis | 1 | 2017 | 199 | 0.140 |
Why?
| Dietary Proteins | 1 | 2019 | 242 | 0.140 |
Why?
| Cell Culture Techniques | 1 | 2017 | 99 | 0.140 |
Why?
| Biomedical Research | 1 | 2019 | 231 | 0.140 |
Why?
| Comorbidity | 2 | 2012 | 618 | 0.140 |
Why?
| Transfection | 1 | 2017 | 357 | 0.130 |
Why?
| Blotting, Western | 3 | 2006 | 602 | 0.130 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2015 | 11 | 0.130 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 30 | 0.130 |
Why?
| Aorta | 1 | 2016 | 160 | 0.130 |
Why?
| Enzyme Activation | 1 | 2015 | 276 | 0.120 |
Why?
| Prodromal Symptoms | 1 | 2014 | 9 | 0.120 |
Why?
| Transcription, Genetic | 2 | 2016 | 371 | 0.120 |
Why?
| Protein Kinases | 1 | 2015 | 72 | 0.120 |
Why?
| Double-Blind Method | 4 | 2021 | 674 | 0.120 |
Why?
| Cell Death | 1 | 2015 | 181 | 0.120 |
Why?
| Actin Cytoskeleton | 1 | 2014 | 22 | 0.120 |
Why?
| Gastroscopy | 1 | 2014 | 19 | 0.120 |
Why?
| Hospital Mortality | 3 | 2018 | 413 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 228 | 0.120 |
Why?
| Protein Binding | 2 | 2008 | 660 | 0.120 |
Why?
| Down-Regulation | 2 | 2016 | 349 | 0.120 |
Why?
| Coronary Disease | 1 | 2014 | 132 | 0.110 |
Why?
| Retrospective Studies | 4 | 2018 | 6117 | 0.110 |
Why?
| Survival Analysis | 3 | 2013 | 659 | 0.110 |
Why?
| Models, Biological | 2 | 2008 | 728 | 0.110 |
Why?
| Pneumonia, Aspiration | 1 | 2012 | 12 | 0.110 |
Why?
| Eukaryotic Initiation Factors | 1 | 2012 | 5 | 0.100 |
Why?
| Argonaute Proteins | 1 | 2012 | 11 | 0.100 |
Why?
| Multigene Family | 1 | 2012 | 56 | 0.100 |
Why?
| Adiponectin | 1 | 2012 | 64 | 0.100 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2013 | 133 | 0.100 |
Why?
| Enteral Nutrition | 1 | 2012 | 146 | 0.100 |
Why?
| Deglutition Disorders | 1 | 2012 | 77 | 0.100 |
Why?
| Gene Expression | 3 | 2016 | 608 | 0.100 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 109 | 0.100 |
Why?
| Forecasting | 1 | 2012 | 150 | 0.100 |
Why?
| Adipocytes | 1 | 2012 | 121 | 0.100 |
Why?
| Length of Stay | 2 | 2018 | 623 | 0.100 |
Why?
| Hypertension | 1 | 2016 | 532 | 0.100 |
Why?
| Career Choice | 1 | 2012 | 111 | 0.090 |
Why?
| Algorithms | 1 | 2014 | 616 | 0.090 |
Why?
| Health Services Needs and Demand | 1 | 2012 | 158 | 0.090 |
Why?
| Time Factors | 4 | 2014 | 2912 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 161 | 0.090 |
Why?
| Diagnosis, Differential | 1 | 2014 | 1036 | 0.090 |
Why?
| Heart Diseases | 1 | 2012 | 208 | 0.090 |
Why?
| Organ Size | 1 | 2010 | 226 | 0.090 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 287 | 0.090 |
Why?
| Cell Nucleus | 1 | 2010 | 184 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1374 | 0.080 |
Why?
| Longitudinal Studies | 2 | 2014 | 673 | 0.080 |
Why?
| Cardiovascular Agents | 1 | 2009 | 54 | 0.080 |
Why?
| Paclitaxel | 1 | 2009 | 84 | 0.080 |
Why?
| Cell Proliferation | 1 | 2013 | 1007 | 0.080 |
Why?
| Curriculum | 1 | 2012 | 404 | 0.080 |
Why?
| Cardiology | 1 | 2010 | 89 | 0.080 |
Why?
| Drug-Eluting Stents | 1 | 2009 | 93 | 0.080 |
Why?
| Piperidines | 1 | 2009 | 97 | 0.080 |
Why?
| NAD | 1 | 2008 | 43 | 0.080 |
Why?
| Pyrazoles | 1 | 2009 | 113 | 0.080 |
Why?
| Health Status | 2 | 2009 | 298 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 604 | 0.080 |
Why?
| Protein Subunits | 1 | 2008 | 77 | 0.080 |
Why?
| Stereotyping | 1 | 2008 | 33 | 0.080 |
Why?
| Serum Response Element | 1 | 2007 | 4 | 0.070 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 130 | 0.070 |
Why?
| Codon, Nonsense | 1 | 2007 | 26 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2012 | 1188 | 0.070 |
Why?
| HeLa Cells | 1 | 2008 | 251 | 0.070 |
Why?
| Placebos | 2 | 2009 | 85 | 0.070 |
Why?
| Models, Genetic | 1 | 2007 | 174 | 0.070 |
Why?
| Myocytes, Cardiac | 1 | 2008 | 125 | 0.070 |
Why?
| Zinc Fingers | 1 | 2006 | 23 | 0.070 |
Why?
| Heart Rate | 1 | 2008 | 292 | 0.070 |
Why?
| Logistic Models | 1 | 2009 | 891 | 0.070 |
Why?
| Sequence Alignment | 1 | 2006 | 121 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 108 | 0.070 |
Why?
| Treatment Outcome | 4 | 2018 | 5138 | 0.070 |
Why?
| Stress, Psychological | 1 | 2008 | 260 | 0.070 |
Why?
| Science | 1 | 2005 | 17 | 0.070 |
Why?
| Middle Aged | 7 | 2017 | 11997 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2009 | 274 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 595 | 0.060 |
Why?
| Binding Sites | 1 | 2006 | 377 | 0.060 |
Why?
| Blood Pressure | 1 | 2008 | 514 | 0.060 |
Why?
| Two-Hybrid System Techniques | 1 | 2004 | 24 | 0.060 |
Why?
| Atrial Natriuretic Factor | 1 | 2004 | 21 | 0.060 |
Why?
| Patient Compliance | 1 | 2006 | 230 | 0.060 |
Why?
| Blotting, Northern | 1 | 2004 | 109 | 0.060 |
Why?
| Immunoprecipitation | 1 | 2004 | 59 | 0.060 |
Why?
| DNA, Complementary | 1 | 2004 | 135 | 0.060 |
Why?
| Sequence Homology, Amino Acid | 1 | 2004 | 146 | 0.060 |
Why?
| Proportional Hazards Models | 3 | 2014 | 406 | 0.060 |
Why?
| Transcriptional Activation | 1 | 2004 | 122 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2012 | 1172 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 159 | 0.060 |
Why?
| Leukocytes, Mononuclear | 2 | 2016 | 116 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2004 | 80 | 0.060 |
Why?
| Glutathione Transferase | 1 | 2004 | 174 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2004 | 162 | 0.060 |
Why?
| Cardiomyopathies | 1 | 2004 | 108 | 0.060 |
Why?
| Echocardiography, Doppler | 1 | 2003 | 52 | 0.060 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 52 | 0.050 |
Why?
| Models, Animal | 1 | 2003 | 233 | 0.050 |
Why?
| Ventricular Dysfunction, Left | 1 | 2003 | 92 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.050 |
Why?
| Aggression | 1 | 2002 | 49 | 0.050 |
Why?
| Dopamine | 1 | 2023 | 171 | 0.050 |
Why?
| Point Mutation | 1 | 2002 | 65 | 0.050 |
Why?
| Risk Factors | 3 | 2018 | 3619 | 0.050 |
Why?
| Drug Administration Schedule | 1 | 2002 | 376 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2006 | 1451 | 0.050 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 152 | 0.050 |
Why?
| Psychiatric Status Rating Scales | 1 | 2002 | 319 | 0.050 |
Why?
| Positron-Emission Tomography | 1 | 2023 | 294 | 0.050 |
Why?
| DNA, Mitochondrial | 1 | 2002 | 112 | 0.050 |
Why?
| Cross-Sectional Studies | 1 | 2006 | 1541 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2021 | 112 | 0.050 |
Why?
| National Institute on Aging (U.S.) | 1 | 2019 | 2 | 0.040 |
Why?
| Qualitative Research | 1 | 2021 | 325 | 0.040 |
Why?
| Europe | 1 | 2019 | 74 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2002 | 942 | 0.040 |
Why?
| Beverages | 1 | 2019 | 68 | 0.040 |
Why?
| Meals | 1 | 2019 | 57 | 0.040 |
Why?
| Registries | 2 | 2013 | 518 | 0.040 |
Why?
| Myocardial Infarction | 2 | 2014 | 382 | 0.040 |
Why?
| Matrix Metalloproteinases | 1 | 2017 | 48 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2003 | 605 | 0.040 |
Why?
| Blood-Brain Barrier | 1 | 2016 | 48 | 0.030 |
Why?
| Polymorphism, Genetic | 1 | 2017 | 181 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 107 | 0.030 |
Why?
| Arginine | 1 | 2017 | 179 | 0.030 |
Why?
| Angiotensin II | 1 | 2016 | 157 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 699 | 0.030 |
Why?
| Analysis of Variance | 1 | 2016 | 565 | 0.030 |
Why?
| Myocardial Revascularization | 1 | 2014 | 13 | 0.030 |
Why?
| Intubation, Gastrointestinal | 1 | 2014 | 26 | 0.030 |
Why?
| Mice, Knockout | 1 | 2016 | 841 | 0.030 |
Why?
| Health Surveys | 1 | 2014 | 232 | 0.030 |
Why?
| Cohort Studies | 1 | 2018 | 1422 | 0.030 |
Why?
| Acute Disease | 1 | 2014 | 369 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 27 | 0.030 |
Why?
| Lymphopenia | 1 | 2012 | 18 | 0.030 |
Why?
| Tunicamycin | 1 | 2012 | 11 | 0.030 |
Why?
| Thapsigargin | 1 | 2012 | 10 | 0.030 |
Why?
| Palmitic Acid | 1 | 2012 | 22 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2014 | 580 | 0.030 |
Why?
| Sex Factors | 1 | 2014 | 693 | 0.030 |
Why?
| Thrombocytopenia | 1 | 2012 | 84 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2014 | 904 | 0.030 |
Why?
| Cognition | 1 | 2014 | 336 | 0.020 |
Why?
| Stents | 1 | 2014 | 338 | 0.020 |
Why?
| RNA | 1 | 2012 | 170 | 0.020 |
Why?
| Stem Cells | 1 | 2012 | 171 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 536 | 0.020 |
Why?
| Liver | 1 | 2016 | 1109 | 0.020 |
Why?
| Survival Rate | 1 | 2013 | 905 | 0.020 |
Why?
| Brazil | 1 | 2010 | 34 | 0.020 |
Why?
| Multicenter Studies as Topic | 1 | 2009 | 84 | 0.020 |
Why?
| Body Mass Index | 1 | 2012 | 652 | 0.020 |
Why?
| Safety | 1 | 2009 | 78 | 0.020 |
Why?
| Perceptual Masking | 1 | 2008 | 11 | 0.020 |
Why?
| Vocabulary | 1 | 2008 | 17 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 248 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 469 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 251 | 0.020 |
Why?
| Administration, Oral | 1 | 2009 | 423 | 0.020 |
Why?
| Attitude | 1 | 2008 | 69 | 0.020 |
Why?
| Young Adult | 1 | 2016 | 3936 | 0.020 |
Why?
| Body Composition | 1 | 2009 | 318 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2009 | 553 | 0.020 |
Why?
| Thrombosis | 1 | 2009 | 249 | 0.020 |
Why?
| Genetic Engineering | 1 | 2005 | 24 | 0.020 |
Why?
| Research | 1 | 2005 | 112 | 0.020 |
Why?
| Adolescent | 1 | 2016 | 6340 | 0.020 |
Why?
| Risk Assessment | 1 | 2009 | 1262 | 0.020 |
Why?
| Health Policy | 1 | 2005 | 153 | 0.020 |
Why?
| Cheek | 1 | 2002 | 9 | 0.010 |
Why?
| Mouth Mucosa | 1 | 2002 | 25 | 0.010 |
Why?
| Mitosis | 1 | 2002 | 92 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 292 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 237 | 0.010 |
Why?
| Gene Deletion | 1 | 2002 | 266 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2002 | 455 | 0.010 |
Why?
| Epithelial Cells | 1 | 2002 | 209 | 0.010 |
Why?
| Prognosis | 1 | 2003 | 1952 | 0.010 |
Why?
| Mutation | 1 | 2002 | 1293 | 0.010 |
Why?
| Infant | 1 | 2002 | 3551 | 0.010 |
Why?
| Child, Preschool | 1 | 2002 | 3853 | 0.010 |
Why?
| Neoplasms | 1 | 2002 | 1233 | 0.010 |
Why?
| Child | 1 | 2002 | 6824 | 0.010 |
Why?
|
|
Wei's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|